Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298818 · ClinicalTrials.gov registry record
Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 25
- Enrollment target
NCT00298818: Completed study, sponsored by Northwell Health.
NCT00298818 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00298818 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy and tolerability in "real-world" clinical practice, of adjunctive zonisamide treatment in adult patients with developmental disabilities and epilepsy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2002-08 |
| Est. Completion | 2008-03 |
What the finished NCT00298818 record still lists
NCT00298818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00298818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00298818 about?
NCT00298818 is a clinical study titled "Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation". The purpose of this study is to assess the efficacy and tolerability in "real-world" clinical practice, of adjunctive zonisamide treatment in adult patients with developmental disabilities and epilepsy.
What is the current status of trial NCT00298818?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2002-08. Estimated completion is 2008-03.
Who is sponsoring clinical trial NCT00298818?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia